Literature DB >> 21983749

Shiga toxin pathogenesis: kidney complications and renal failure.

Tom G Obrig1, Diana Karpman.   

Abstract

The kidneys are the major organs affected in diarrhea-associated hemolytic uremic syndrome (D(+)HUS). The pathophysiology of renal disease in D(+)HUS is largely the result of the interaction between bacterial virulence factors such as Shiga toxin and lipopolysaccharide and host cells in the kidney and in the blood circulation. This chapter describes in detail the current knowledge of how these bacterial toxins may lead to kidney disease and renal failure. The toxin receptors expressed by specific blood and resident renal cell types are also discussed as are the actions of the toxins on these cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21983749      PMCID: PMC3779650          DOI: 10.1007/82_2011_172

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  248 in total

Review 1.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

2.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

3.  Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7.

Authors:  Krystle L Mohawk; Angela R Melton-Celsa; Cory M Robinson; Alison D O'Brien
Journal:  Vaccine       Date:  2010-05-14       Impact factor: 3.641

4.  Markers of endothelial cell activation and injury in childhood haemolytic uraemic syndrome.

Authors:  C H Nevard; A D Blann; K M Jurd; G B Haycock; B J Hunt
Journal:  Pediatr Nephrol       Date:  1999-08       Impact factor: 3.714

Review 5.  Shiga toxins--from cell biology to biomedical applications.

Authors:  Ludger Johannes; Winfried Römer
Journal:  Nat Rev Microbiol       Date:  2009-12-21       Impact factor: 60.633

6.  The functional state of neutrophils correlates with the severity of renal dysfunction in children with hemolytic uremic syndrome.

Authors:  Gabriela C Fernandez; Sonia A Gomez; Maria V Ramos; Leticia V Bentancor; Romina J Fernandez-Brando; Veronica I Landoni; Laura Lopez; Flavia Ramirez; Mario Diaz; Marta Alduncin; Irene Grimoldi; Ramon Exeni; Martin A Isturiz; Marina S Palermo
Journal:  Pediatr Res       Date:  2007-01       Impact factor: 3.756

7.  Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes.

Authors:  Kellie R K Winter; William C Stoffregen; Evelyn A Dean-Nystrom
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

8.  Inhibition of p38 mitogen-activated protein kinase ameliorates cytokine up-regulated shigatoxin-1 toxicity in human brain microvascular endothelial cells.

Authors:  Peter K Stricklett; Alisa K Hughes; Donald E Kohan
Journal:  J Infect Dis       Date:  2004-12-22       Impact factor: 5.226

9.  Shiga toxin 2 causes apoptosis in human brain microvascular endothelial cells via C/EBP homologous protein.

Authors:  Jun Fujii; Katie Wood; Fumiko Matsuda; Benedito A Carneiro-Filho; Keilo H Schlegel; Takashi Yutsudo; Beth Binnington-Boyd; Clifford A Lingwood; Fumiko Obata; Kwang S Kim; Shin-ichi Yoshida; Tom Obrig
Journal:  Infect Immun       Date:  2008-06-09       Impact factor: 3.441

10.  A novel renal perspective of preeclampsia: a look from the podocyte.

Authors:  Daniel E Henao; Peter W Mathieson; Moin A Saleem; Julio C Bueno; Angela Cadavid
Journal:  Nephrol Dial Transplant       Date:  2007-01-18       Impact factor: 5.992

View more
  26 in total

Review 1.  The role of the antimicrobial peptide cathelicidin in renal diseases.

Authors:  Milan Chromek
Journal:  Pediatr Nephrol       Date:  2014-08-27       Impact factor: 3.714

2.  Effects of Shiga toxin type 2 on a bioengineered three-dimensional model of human renal tissue.

Authors:  Teresa M DesRochers; Erica Palma Kimmerling; Dakshina M Jandhyala; Wassim El-Jouni; Jing Zhou; Cheleste M Thorpe; John M Leong; David L Kaplan
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

Review 3.  Role of Shiga/Vero toxins in pathogenesis.

Authors:  Fumiko Obata; Tom Obrig
Journal:  Microbiol Spectr       Date:  2014-06

Review 4.  Citrobacter rodentium(ϕStx2dact), a murine infection model for enterohemorrhagic Escherichia coli.

Authors:  Cheleste M Thorpe; Amanda R Pulsifer; Marcia S Osburne; Sivapriya Kailasan Vanaja; John M Leong
Journal:  Curr Opin Microbiol       Date:  2021-12-17       Impact factor: 7.584

Review 5.  Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.

Authors:  Carlamaria Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2017-12-06       Impact factor: 3.714

Review 6.  Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).

Authors:  Ramon Alfonso Exeni; Romina Jimena Fernandez-Brando; Adriana Patricia Santiago; Gabriela Alejandra Fiorentino; Andrea Mariana Exeni; Maria Victoria Ramos; Marina Sandra Palermo
Journal:  Pediatr Nephrol       Date:  2018-01-25       Impact factor: 3.714

7.  The oxidative stress induced in vivo by Shiga toxin-2 contributes to the pathogenicity of haemolytic uraemic syndrome.

Authors:  S A Gomez; M J Abrey-Recalde; C A Panek; N F Ferrarotti; M G Repetto; M P Mejías; G C Fernández; S Vanzulli; M A Isturiz; M S Palermo
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

8.  Eculizumab in STEC-HUS: need for a proper randomized controlled trial.

Authors:  Sebastian Loos; Jun Oh; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2018-05-17       Impact factor: 3.714

9.  Eliglustat prevents Shiga toxin 2 cytotoxic effects in human renal tubular epithelial cells.

Authors:  Daiana S Sánchez; Lilian K Fischer Sigel; Alejandro Balestracci; Cristina Ibarra; María M Amaral; Claudia Silberstein
Journal:  Pediatr Res       Date:  2021-06-21       Impact factor: 3.756

10.  The antimicrobial peptide cathelicidin protects mice from Escherichia coli O157:H7-mediated disease.

Authors:  Milan Chromek; Ida Arvidsson; Diana Karpman
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.